Gentulizumab

DB18148InvestigationalProtein Based Therapies

Gentulizumab: Overview.

Mechanism: Pharmacologically active on Leukocyte surface antigen CD47
Curator reviewed
Also known as: GENTULIZUMAB (anti-CD47 Humanized Monoclonal Antibody)

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gentulizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.